Amoli Organics Limited
Sahil R. Dobariya is a Chemical Engineering graduate from R. N. G. Patel Institute of Technology, with experience in the pharmaceutical industry. Currently serving as an Officer at Glenmark Pharmaceuticals since March 2023, Sahil previously held the position of Production Officer at Cadila Pharmaceuticals Limited from August 2022 to March 2023. Prior experience includes roles as Officer in production at Amoli Organics Limited and as a trainee officer in the production department. An internship trainee at Zydus Cadila Healthcare Limited in June and July 2019 provided foundational industry experience. Educational background also includes higher secondary education at Harekrishna Vidhyalaya and secondary education at Nalanda International School.
This person is not in any teams
This person is not in any offices
Amoli Organics Limited
1 followers
Established in 1992,Amoli Organics is a leading manufacturer of APIs with headquarters in Mumbai, India. Amoli has been working collaboratively with some of the leading global healthcare players since 3 decades. Our strength comes from our expertise in process chemistry further bolstered by our EDQM and USFDA approved facilities allowing us to cater to the needs of the pharmaceutical industry globally. We offer APIs from a wide range of therapeutic classes like Antiepileptic, Antidiabetic, Antidepressants ,NSAIDS, Hypolipidemics etc. With the support our state-of-the-art R&D centre, we are constantly expanding our product range and foraying into newer therapeutic categories. With a strong team of 1100 employees, Amoli has been able to carve out a place for itself in India's booming pharmaceutical industry. With a stellar regulatory track record, Amoli enjoys the reputation of being a preferred and reliable supplier of several APIs. Our strategy is to keep evolving on all fronts (quality, regulatory and business) in order to remain competitive and relevant in the industry, while ensuring our foundational roots remain intact.